Literature DB >> 6201726

A common idiotope on human rheumatoid factors identified by a hybridoma antibody.

D A Carson, S Fong.   

Abstract

Human monoclonal and polyclonal anti-IgG autoantibodies [rheumatoid factors (RFs)] are composed primarily of kappa light chains, and may display cross-reactive idiotypes. However, the nature of the shared idiotope(s) has remained unclear. We have prepared a murine hybridoma antibody (17-109) that recognizes an idiotope present on 30% (3/10) of human IgM-RF paraproteins, and absent on immunoglobulins without RF activity. The idiotope was measurable on isolated, intact kappa light chains, but not on light-chain tryptic peptides, nor on isolated heavy chains. A comparison of the binding to 17-109 of five IgM-RF paraproteins, with known kappa chain amino acid sequences, suggested a relationship between the idiotope recognized by the hybridoma and the complementarity-determining regions. The serum of patients with rheumatoid arthritis contained idiotope positive material that bound specifically to a 17-109 immunoadsorbent column. Moreover, the 17-109 anti-idiotope antibody partially inhibited the binding to IgG of IgM-RF and IgA-RF in serum, but did not effect the binding to antigen of IgM and IgA anti-tetanus toxoid antibodies. These results suggest that a significant proportion of IgM-RF paraproteins share an idiotope located at or near the complementarity-determining regions of the kappa light chain. Human serum RFs include a kappa light chain family that is idiotopically related to the kappa chains on IgM-RF paraproteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6201726     DOI: 10.1016/0161-5890(83)90116-5

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  36 in total

1.  Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Authors:  W A Marasco; J Bagley; C Zani; M Posner; L Cavacini; W A Haseltine; J Sodroski
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

2.  Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes.

Authors:  T J Kipps; S F Duffy
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 3.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  Expression of rheumatoid factor associated cross-reactive idiotopes by glandular B cells in Sjögren's syndrome.

Authors:  E M Deacon; J B Matthews; A J Potts; J Hamburger; R A Mageed; R Jefferis
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

5.  Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D A Fox; B R Smith
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

6.  Cross-reactive variable-region associated epitopes of human IgG1 lambda paraprotein detected by a monoclonal antibody panel.

Authors:  L C Walker; S Dhut; W M Gregory; J A Habeshaw
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

7.  Monoclonal antibodies defining a minor and a private idiotope on human rheumatoid factors.

Authors:  J L Pasquali; D Storck
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

8.  Common IgA and IgM rheumatoid factor idiotypes in autoimmune diseases.

Authors:  A E Gharavi; B M Patel; G R Hughes; K B Elkon
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

9.  Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia.

Authors:  D Sansonno; G Lauletta; L Nisi; P Gatti; F Pesola; N Pansini; F Dammacco
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

10.  Effect of 51p1-related gene copy number (V1-69 locus) on production of hepatitis C-associated cryoglobulins.

Authors:  E H Sasso; P Ghillani; L Musset; J C Piette; P Cacoub
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.